<DOC>
	<DOCNO>NCT03098108</DOCNO>
	<brief_summary>The investigator conduct study evaluate efficacy adverse effect salvage concurrent chemo-proton therapy ( CCPT ) without surgical resection previously irradiate recurrent rectal cancer .</brief_summary>
	<brief_title>Concurrent Chemo-proton Radiotherapy With Without Resection Spacer Insertion Loco-regional Recurrence Previous Irradiated Rectal Cancer</brief_title>
	<detailed_description>The obtain local control previously irradiate recurrent rectal cancer crucial survival prolongation well quality life patient . But , easy get surgery and/or conventional radiotherapy ( RT ) limitation RT dose . Proton therapy unique advantage show superior dose distribution focus tumor escape surround normal tissue use `` Bragg-peak '' .</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<criteria>previously diagnose rectal cancer receive curative intent treatment diagnose recurrent rectal cancer either pathology radiologic exam discuss tumor board recommend proton therapy previous history pelvic area radiotherapy Eastern Cooperative Oncology Group performance status 0 2 informed consent present study consent contraception 6 month study participation maintain bone marrow function ( absolute neutrophil count ≥ 1,2 * 109/L , platelet count ≥ 100 * 109/L ) maintain renal , hepatic function creatinine clearance ≥ 50 mL/minute total bilirubin ≥ 2.2 mg/dl alkaline phosphatase ≥ 192 U/L Pregnant and/or breastfeed woman Less 12 week expect survival Uncontrolled active comorbidity</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>